title: Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
authors.affiliation: University of Colorado School of Medicine, Denver, Colorado, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Berman
authors.forename: Lauren
authors.initials: L
authors.lastname: Seeberger
authors.forename: Rajeev
authors.initials: R
authors.lastname: Kumar
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects; D004185:Disability Evaluation; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013995:Time; D014103:Torticollis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018726:Anti-Dyskinesia Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A